United Therapeutics Corp
XNAS: UTHR
United Therapeutics Corp Live Stock Price Today, Share Analysis and Chart
about
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...
Read More
532.82
-11.89
(-2.18%)
622.2K
XNAS Volume
XNAS 12 Mar, 2026 5:30 PM (EDT)
Insider Trade
Martine Rothblatt, Chairperson & CEO of United Therapeutics, sells 9.5K shares worth $5.1 million
See details
Low Financial Strength
Mid Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks
View Similar
Embed DVM
United Therapeutics Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..